WuXi AppTec plans China-HK share sale

By Jonathan Breen
25 Mar 2020

Chinese pharmaceutical company WuXi AppTec Co is planning to raise primary equity through an issue of H-shares and its Shanghai-listed A-shares.

The company’s board of directors approved a plan on Tuesday to issue as many as 95.5m H-shares, equal to 40% of that outstanding, and up to 75m A-shares, representing 20% of the existing A-share stock.

WuXi expects to raise up to Rmb6.5bn ($923.2m) from the A-share placement, while ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial